GALLBLADDER CANCER - IMMUNOHISTOCHEMICAL EXPRESSION OF P-29 ESTROGEN-RECEPTOR ASSOCIATED PROTEIN AND PS2 ESTROGEN-INDUCED PROTEIN

Citation
I. Roa et al., GALLBLADDER CANCER - IMMUNOHISTOCHEMICAL EXPRESSION OF P-29 ESTROGEN-RECEPTOR ASSOCIATED PROTEIN AND PS2 ESTROGEN-INDUCED PROTEIN, Revista Medica de Chile, 123(11), 1995, pp. 1333-1340
Citations number
39
Categorie Soggetti
Medicine, General & Internal
Journal title
ISSN journal
00349887
Volume
123
Issue
11
Year of publication
1995
Pages
1333 - 1340
Database
ISI
SICI code
0034-9887(1995)123:11<1333:GC-IEO>2.0.ZU;2-J
Abstract
The high frequency of gallbladder cancer in women suggests a role for estrogens in its development. The aim of this study was to study the i mmunohistochemical expression of p29 estrogen receptor associated prot ein and pS2 estrogen induced protein in 111 pathological samples of ga llbladder carcinoma, coming from 88 women and 23 men, 30 metastases of gallbladder cancer, coming from 25 women and 5 men and in 25 non-tumo ral gallbladders. In the latter, p29 protein was positive in 12 sample s (48%) and pS2 in 15 cases (60%). p29 was positive in 40% and pS2 in 32% of tumors. p29 expressed with higher frequency in metastases than in primary tumors (57 and 31% respectively, p<0.02). Early tumors had a significantly lower expression of p29 than advanced tumors or than m etastases. Both proteins expressed in 18% of samples (synchronic expre ssion) whereas one of both proteins did so in 60% of cases (asynchroni c expression). We conclude that most gallbladder cancer samples expres s proteins associated to estrogen receptor or induced by estrogens.